Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 20
1
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Should I stay or should I go? Connecting bird behavior during migration to fat stores and antioxidant capacity

Thank you to our backers for $5600! We actually need up to $24000 - please keep donating! In the fall, most...

How have pigeons in eastern North America evolved?

This study aims to better understand how birds can micro-evolve in a newly colonized environment. I hypothesize...

Backer Badge Funded